Dallas, Texas — According to state and local development sources, Sofie Biosciences plans to invest $6,000,000.00 to build out 4,390 square feet of new space in Dallas. The company plans to occupy the new space at 4447 Brass Way in Dallas, on or about January 1, 2026. According to the company website Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value radiopharmaceutical intellectual property, we are poised to deliver on the promise of radiopharmaceuticals.

To learn more about Sofie Biosciences, visit http://sofie.com/

Company Contact:
Patrick Phelps, Chief Executive Officer
patrick.phelps@sofie.com
https://www.linkedin.com/in/patrick-w-phelps-1a1b413/
703-787-7900

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.